Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study

Journal of Hypertension

Volumn 19, Issue 11, 2001, Pages 1949-1956

  Svetkey, Laura P ^a,h   Moore, Thomas J ^b,c,i   Simons Morton, Denise G ^d   Appel, Lawrence J ^e   Bray, George A ^f   Sacks, Frank M ^b   Ard, Jamy D ^a   Mortensen, Richard M ^b,j   Mitchell, Steven R ^g,k   Conlin, Paul R ^b   Kesari, Madhuri ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^g CENTER FOR HEALTH RESEARCH   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

more..

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blood pressure; DASH; Diet; Genetics; Hypertension

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0034767801     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200111000-00004     Document Type: Article

References (51)

1. Plasma renin activity during supine exercise in offspring of hypertensive parents
2. Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects
3. High blood pressure in transgenic mice carrying the rat angiotensinogen gene
4. Genetic control of blood pressure and the angiotensinogen locus
5. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four corners approach to the identification of genetic determinants of blood pressure
6. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans
7. Molecular basis of human hypertension: Role of angiotensinogen
8. Haplotypes of angiotensinogen in essential hypertension
9. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children
10. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites
11. M235T variant of the human angiotensinogen gene in unselected hypertensive patients
12. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians
13. Angiotensinogen M235T variant and salt sensitivity in young normotensive Caucasians
14. Angiotensinogen gene and blood pressure in the Japanese population
15. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese
16. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study
17. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate
18. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: The PEGASE study. Projet d'étude des gènes de l'hypertension artérielle sévère ȧ modérée essentielle
19. Carotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension
20. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure
21. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: Trials of hypertension prevention, phase II
22. Genetics of diabetic nephropathy
23. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: The Skaraborg Hypertension and diabetes project
24. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension
25. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study
26. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples
27. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus
28. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus
29. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction
30. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy
31. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy
32. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
33. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis
34. Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis
35. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy
36. Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients
37. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients
38. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy
39. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure
40. Dietary Approaches to Stop Hypertension: Rationale, design, and methods
41. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
42. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene
43. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Génétique de la Nephropathie Diabétique (GENEDIAB) study group
44. A clinical trial of the effects of dietary patterns on blood pressure
45. Effects of dietary patterns on blood pressure: Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial
46. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans
47. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro
48. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese
49. Effect of the angiotensinogen gene Met235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations
50. A molecular variant of angiotensinogen associated with preeclampsia
51. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: The ECTIM Study